Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 18 and 60 years old.
- People who have been diagnosed with multiple sclerosis (MS) involving relapses or worsening, along with lasting disability, as confirmed by a specialist neurologist.
- People with an EDSS score (a standard measure of MS-related disability) between 3 and 6, including those scoring exactly 3 or 6.
- People whose MS has significantly affected either their balance and coordination (cerebellar function) or their muscle strength and movement (pyramidal function), as measured by specific parts of the EDSS scale.
- People whose MS is currently showing signs of active disease.
- People who have previously received certain chemotherapy-type medicines (such as mitoxantrone or cyclophosphamide) and whose bone marrow tests show normal results before the trial begins.
- People with no signs of liver inflammation or scarring.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who show signs of a bone marrow disorder (myelodysplasia) or certain blood cell problems not caused by an autoimmune condition.
- People who have received chemotherapy-type medicines within one month before enrolling in the trial.
- People who have any active or ongoing infection, such as herpes, chickenpox-related viruses, HIV, hepatitis, syphilis, or similar infections.
- People who have received chemotherapy-type medicines within one month before enrolling in the trial (confirm with trial site, as this criterion appears twice in the source).
- People who currently have, or have had, a cancerous tumour within the last five years.
- People who have significant problems with their heart, kidneys, lungs, liver, or other major organs.
- People whose life expectancy is seriously limited by another medical condition.
- People who are pregnant or at risk of becoming pregnant.
- People who are unable to provide written consent to participate, in line with research ethics requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Qiang Liu, M.D.,Ph.D, Tianjin Medical University General Hospital
Phone: +86 15022439149
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
3 year MS activity free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.